 This Phase I trial will test Antimicrobial TheraGauze ATG as an antimicrobial wound packing for patients presenting to an Emergency Department with skin abscess furunculosis. Subjects will either receive ATG or standard of care wound packing cotton wick or iodoform wick. Subjects will return to the ED in 2 days for wound packing removal and reassessment of their wounds and symptomatology. A final followup will be performed by a physician and study coordinator in an outpatient setting on day 7. 